DESHPANDE NITIN GOPAL 4
4 · ECLIPSYS CORP · Filed Aug 26, 2010
Insider Transaction Report
Form 4
ECLIPSYS CORPECLP
DESHPANDE NITIN GOPAL
President, Eclipsys India
Transactions
- Disposition to Issuer
Common Stock
2010-08-24−3,333→ 0 total - Disposition to Issuer
Stock Option
2010-08-24−15,000→ 0 totalExercise: $7.97→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−25,000→ 0 totalExercise: $20.07→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−20,000→ 0 totalExercise: $22.07→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−45,000→ 0 totalExercise: $7.97→ Common Stock (45,000 underlying)
Footnotes (5)
- [F1]As the transaction was fully described in the joint proxy statement dated July 14, 2010, as filed with the SEC, each Issuer share was converted into 1.2 shares of common stock of Allscripts Healthcare Solutions, Inc. pursuant to a merger of Issuer with a wholly-owned subsidiary of Allscripts. Shares that were converted included 1,666 shares of Issuer unvested restricted stock that will be subject to the same terms as specified in the original grant. Disposition by Reporting Person was approved by Issuer board of directors.
- [F2]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 15,833 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F3]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 12,083 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F4]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 5,313 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F5]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 15,938 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.